U.S. markets close in 4 hours 41 minutes
  • S&P 500

    4,041.00
    +23.23 (+0.58%)
     
  • Dow 30

    33,783.93
    +66.84 (+0.20%)
     
  • Nasdaq

    11,503.38
    +109.57 (+0.96%)
     
  • Russell 2000

    1,916.21
    +30.49 (+1.62%)
     
  • Crude Oil

    78.96
    +1.06 (+1.36%)
     
  • Gold

    1,943.50
    +4.30 (+0.22%)
     
  • Silver

    23.79
    +0.06 (+0.24%)
     
  • EUR/USD

    1.0865
    +0.0008 (+0.08%)
     
  • 10-Yr Bond

    3.5310
    -0.0200 (-0.56%)
     
  • GBP/USD

    1.2321
    -0.0033 (-0.27%)
     
  • USD/JPY

    130.1410
    -0.2170 (-0.17%)
     
  • BTC-USD

    23,134.37
    -92.21 (-0.40%)
     
  • CMC Crypto 200

    524.89
    +6.10 (+1.17%)
     
  • FTSE 100

    7,774.18
    -10.69 (-0.14%)
     
  • Nikkei 225

    27,327.11
    -106.29 (-0.39%)
     

64 Stocks Moving In Friday's Mid-Day Session

Gainers

  • Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the estimated price range of $4-$6, for raising gross proceeds of $10 million.

  • Ontrak, Inc. (NASDAQ: OTRK) shares climbed 44.6% to $14.01 after the company reported better-than-expected Q3 results and issued FY21 sales guidance.

  • FAT Brands Inc. (NASDAQ: FATBB) gained 41.3% to $24.02 after the company reported fiscal third quarter 2021 financial results for the 13-week period ending September 26, 2021.

  • ReWalk Robotics Ltd. (NASDAQ: RWLK) climbed 31.8% to $1.70 after the company announced its ReBoot device has been granted designation as a Breakthrough Device by the FDA.

  • Alzamend Neuro, Inc. (NASDAQ: ALZN) gained 28% to $2.9450.

  • 2seventy bio Inc. (NASDAQ: TSVT) jumped 27.8% to $34.06.

  • Chinook Therapeutics, Inc. (NASDAQ: KDNY) rose 25.8% to $15.40. Chinook Therapeutics recently highlighted 6 ePoster presentations on BION-1301, Atrasentan programs at the American Society Of Nephrology Kidney Week.

  • Shake Shack Inc. (NYSE: SHAK) gained 24% to $96.82 after the company reported better-than-expected Q3 EPS results. BTIG upgraded Shake Shack from Neutral to Buy.

  • BigCommerce Holdings, Inc. (NASDAQ: BIGC) jumped 23.1% to $56.42 after the company reported better-than-expected Q3 results and issued FY21 sales guidance above estimates.

  • Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) gained 22.6% to $35.83 following upbeat Q3 results.

  • Hudson Global, Inc. (NASDAQ: HSON) rose 20.4% to $22.21 after reporting Q3 results.

  • Alimera Sciences, Inc. (NASDAQ: ALIM) jumped 19.9% to $5.40. Alimera Sciences Director James R Largent acquired a total of 10000 shares at an average price of $4.31.

  • Assertio Holdings, Inc. (NASDAQ: ASRT) shares gained 19% to $1.32 after the company posted upbeat quarterly results.

  • Codexis, Inc. (NASDAQ: CDXS) gained 19% to $41.59 after reporting a surprise quarterly profit.

  • Apollo Medical Holdings, Inc. (NASDAQ: AMEH) surged 18.3% to $85.67 following strong quarterly results.

  • Farmer Bros. Co. (NASDAQ: FARM) gained 17.8% to $8.83 following upbeat quarterly results.

  • Canada Goose Holdings Inc. (NASDAQ: GOOS) jumped 17.3% to $47.43 after the company reported second-quarter FY22 sales growth of 40.3% year-on-year to C$232.9 million. Canada Goose expects FY22 revenue of C$1.125 billion - C$1.175 billion, compared to the prior outlook of exceeding C$1.00 billion.

  • Endo International plc (NASDAQ: ENDP) rose 16.9% to $5.78 after the company posted strong Q3 results and raised FY21 forecast.

  • Borr Drilling Limited (NYSE: BORR) rose 16.7% to $1.2254 after reporting preliminary results for the third quarter.

  • Synaptics Incorporated (NASDAQ: SYNA) gained 16.2% to $256.63 following better-than-expected quarterly results.

  • JFrog Ltd. (NASDAQ: FROG) rose 15.4% to $40.94 after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.

  • IGM Biosciences, Inc. (NASDAQ: IGMS) gained 14.5% to $60.66. Wedbush upgraded IGM Biosciences from Neutral to Outperform and announced $82 price target.

  • Confluent, Inc. (NASDAQ: CFLT) gained 13.8% to $83.80 after the company reported better-than-expected Q3 EPS and sales results and issued Q4 and FY21 revenue guidance above estimates.

  • Live Nation Entertainment, Inc. (NYSE: LYV) jumped 13.5% to $122.08 following strong quarterly results.

  • Expedia Group, Inc. (NASDAQ: EXPE) shares gained 12.5% to $177.21 as the company reported stronger-than-expected earnings and sales results for the third quarter on Thursday.

  • JFrog Ltd. (NASDAQ: FROG) gained 12.5% to $39.88 after the company reported better-than-expected Q3 results and issued EPS and sales guidance above estimates.

  • Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) gained 12.2% to $23.36 following positive data from Pfizer for its COVID-19 oral antiviral treatment candidate.

  • Revlon, Inc. (NYSE: REV) surged 11.8% to $13.27 on narrower-than-expected quarterly loss.

  • Airbnb, Inc. (NASDAQ: ABNB) rose 11.3% to $198.60 after the company reported its best quarter on record, with earnings and sales figures surpassing market expectations.

  • Bloom Energy Corporation (NYSE: BE) rose 9.4% to $33.00 after the company reported quarterly results.

  • The Goodyear Tire & Rubber Company (NASDAQ: GT) gained 9.4% to $23.46 on upbeat quarterly results.

  • Datadog, Inc. (NASDAQ: DDOG) rose 8.7% to $181.41 after the company reported better-than-expected Q3 results and issued FY21 guidance above estimates.

  • Fluor Corporation (NYSE: FLR) rose 8.6% to $22.03. Fluor stated that the Fluor Petrosea Joint Organization (FPJO) joint venture has been selected by PT Freeport Indonesia to install a new grinding mill at Grasberg copper and gold mining district in Papua, Indonesia.

  • Pfizer Inc. (NYSE: PFE) gained 8.3% to $47.49 after the company announced its COVID-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of a Phase 2/3 study.

  • Pinterest, Inc. (NYSE: PINS) rose 6.1% to $46.28 following Q3 results. Pinterest reported upbeat results for its third quarter on Thursday. However, the company also posted a shortfall in monthly active users.

  • Funko, Inc. (NASDAQ: FNKO) shares rose 5.5% to $18.37 after the company reported upbeat Q3 earnings and issued strong FY21 forecast.

Check out these big penny stock gainers and losers

Losers

  • Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) shares dipped 73.9% to $9.40 after announcing disappointing results from the INTRIGUE Phase 3 study of Qinlock in patients with gastrointestinal stromal tumor (GIST) previously treated with Novartis AG's (NYSE: NVS) Gleevec (imatinib). The study did not meet the primary endpoint of improved progression-free survival (PFS) compared with the standard of care Pfizer Inc's (NYSE: PFE) Sutent (sunitinib).

  • Evaxion Biotech A/S (NASDAQ: EVAX) fell 43.8% to $7.12 after the company priced 3.43 million ADS offering at $7 per ADS.

  • BioRestorative Therapies, Inc. (NASDAQ: BRTX) fell 39.6% to $8.15. BioRestorative therapies priced its $23 million public offering and uplisting to the Nasdaq Capital Market.

  • Emergent BioSolutions Inc. (NYSE: EBS) dropped 37.8% to $32.72 after reporting a loss for the third quarter.

  • Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) fell 35.6% to $19.15 following downbeat quarterly results.

  • Peloton Interactive, Inc. (NASDAQ: PTON) shares fell 33.3% to $57.43 after the company reported worse-than-expected Q1 results and issued FY22 sales guidance below estimates.

  • Adagio Therapeutics, Inc. (NASDAQ: ADGI) dropped 31.3% to $20.82.

  • Puma Biotechnology, Inc. (NASDAQ: PBYI) shares fell 30.8% to $4.4250 after reporting a loss for the third quarter.

  • Applied Optoelectronics, Inc. (NASDAQ: AAOI) dipped 28.4% to $6.18. S&P Dow Jones Indices said Loyalty Ventures will join S&P SmallCap 600, replacing Applied Optoelectronics.

  • TDH Holdings, Inc. (NASDAQ: PETZ) fell 24.4% to $3.22. TDH Holdings shares jumped around 80% on Thursday after the company announced it entered into a securities purchase agreement for a registered direct offering and closed the offering, raising $9.9 million in gross proceeds from the sale.

  • CPI Card Group Inc. (NASDAQ: PMTS) fell 22.9% to $23.54 after reporting Q3 results.

  • New Found Gold Corp. (NASDAQ: NFGC) dipped 22.8% to $5.75. New Found issued an update on its QA/QC program and announced collaboration with MSALABS to utilize Chrysos PhotonAssayTM methods for its Queensway project.

  • Nektar Therapeutics (NASDAQ: NKTR) fell 22.6% to $12.88 following weak quarterly sales.

  • SelectQuote, Inc. (NYSE: SLQT) dropped 21% to $10.33 following Q1 results.

  • Mullen Automotive Inc. (NASDAQ: MULN) dropped 20.9% to $10.35. Mullen Automotive commenced trading on the NASDAQ.

  • NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) fell 20.7% to $7.07. The FDA declined the emergency use authorization (EUA) for NRx Pharmaceuticals' Zyesami (aviptadil).

  • Icosavax, Inc. (NASDAQ: ICVX) dipped 18.8% to $27.50.

  • Aditxt, Inc. (NASDAQ: ADTX) shares fell 18.7% to $2.04 after surging 36% on Thursday.

  • BioNTech SE (NASDAQ: BNTX) dropped 17.2% to $226.70 following positive data from Pfizer for its COVID-19 oral antiviral treatment candidate.

  • Dynavax Technologies Corporation (NASDAQ: DVAX) fell 14.9% to $17.67 after reporting a loss for the third quarter.

  • Insignia Systems, Inc. (NASDAQ: ISIG) fell 14.6% to $6.33.

  • AMN Healthcare Services, Inc. (NYSE: AMN) dropped 14.4% to $96.25 following Q3 results.

  • Tenneco Inc. (NYSE: TEN) fell 13.3% to $12.05 following Q3 results.

  • Redbox Entertainment Inc. (NASDAQ: RDBX) fell 13% to $15.60 after surging 45% on Thursday. Canaccord Genuity initiated coverage on Redbox Entertainment with a Buy rating and announced a price target of $25.

  • Teradata Corporation (NYSE: TDC) dropped 13% to $49.47 following Q3 results.

  • Novavax, Inc. (NASDAQ: NVAX) fell 11.5% to $158.64 after reporting quarterly results.

  • Chembio Diagnostics, Inc. (NASDAQ: CEMI) fell 11.4% to $2.17 after reporting a wider-than-expected quarterly loss.

  • bluebird bio, Inc. (NASDAQ: BLUE) shares fell 8.3% to $14.96. bluebird completed the tax-free spin-off of its oncology programs and portfolio into 2seventy bio, Inc.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.